bronchitis%20-%20chronic%20in%20acute%20exacerbation
BRONCHITIS - CHRONIC IN ACUTE EXACERBATION

Chronic bronchitis is an infection of the trachea and bronchi for at least 3 consecutive months for more than 2 consecutive years.
The patient experiences symptoms of increase in dyspnea, sputum volume and sputum purulence over baseline on most days.

Diagnosis is basically based on clinical presentation.

Drug Information

Indication: Short-term treatment of upper & lower resp tract, skin & soft tissue, GUT infections. Tab & inj Sh...

Indication: Acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, community-acquired & nosoco...

Indication: Infections of nose-pharynx tract (tonsillitis, pharyngitis) & of paranasal sinuses; lower resp tract: bron...

Indication: Infections of the resp tract, middle ear (otitis media), paranasal sinuses (sinusitis) especially caused by gm...

Indication: Upper & lower resp tract infection, upper & lower UTI, peritonitis, cholecystitis, cholangitis & o...

Indication: Lower resp tract, complicated & uncomplicated UTI, intra-abdominal, skin & skin structure infections; ...

Indication: Upper & lower resp tract infections including sinusitis, otitis media & epiglottitis, bacterial pneumo...

Indication: Infections caused by susceptible organisms in lower resp tract (eg, bronchitis, pneumonia), skin & soft ti...

Indication: Tab/powd for oral susp Lower resp tract infections including bronchitis & pneumonia; skin & soft tissu...

Indication: Resp; GUT, ophth, skin & soft tissue, biliary tract, GI & ENT infections. Cholecystitis & cholangi...

1  /  22
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
21 Feb 2019
Obesity, low cardiorespiratory fitness and their combination strongly correlated with chronic disability later in life owing to a wide range of diseases and causes, suggests a recent study.
Roshini Claire Anthony, 18 Dec 2018

Early initiation of the antimicrobial combination of ceftolozane and tazobactam may improve outcomes in patients with multidrug-resistant Pseudomonas aeruginosa infections, according to results of a US-based study.